DBI
NYSE Designer Brands Inc. Class A$5.81 ↑ +0.00 (+0.00%) Trading Up from the previous close of $5.81, $0.04 below the day’s high of $5.85
- YTD change
- -21.80%
- vs 20-day SMA
- -4.91%
- vs 200-day SMA
- -11.29%
Price ranges
Price & Performance
-0.95 (-14.05%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 83.2% away from all-time highs of $34.63
- DBI is down 22% since the beginning of the year
- DBI is up 83% over the past 12 months
- DBI is down 1% over the past 1 month
- 23% of all DBI investors are betting against DBI
- Number of investors short DBI has gone down 15% versus last month
DBI reads neutral: price sits below both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +72.9%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -4.13%
- vs 8-day SMA
- -2.06%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Designer Brands, Inc. engages in the design, production, and retail of footwear and accessory brands. It operates through the following segments: U.S. Retail, Canada Retail, Brand Portfolio, and Others. The U.S. Retail segment focuses on stores operated in the U.S. under the DSW Designer Shoe Warehouse banner and its related e-commerce site. The Canada Retail segment comprises stores operated in Canada under The Shoe Company, Shoe Warehouse, and DSW Designer Shoe Warehouse banners and related e-commerce sites. The Brand Portfolio segment includes sales from wholesale, First Cost, and direct-to-consumer e commerce sites. The Other segment refers to the ABG and Ebuys business. The company was founded on January 20, 1969 and is headquartered in Columbus, OH.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.